Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR3C1 | P04150 | 6/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.51 |
| ▸ | CYP2C19 | P33261 | 4/20 | 0.46 |
| ▸ | HIF1A | Q16665 | 5/20 | 0.46 |
| ▸ | PGR | P06401 | 4/20 | 0.46 |
| ▸ | HRH1 | P35367 | 1/20 | 0.46 |
| ▸ | SERPINA6 | P08185 | 5/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 7/20 | 0.46 |
| ▸ | SHBG | P04278 | 5/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | NR3C2 | P08235 | 1/20 | 0.46 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 4/20 | 0.45 |
| ▸ | TSHR | P16473 | 3/20 | 0.45 |
| ▸ | BLM | P54132 | 1/20 | 0.45 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2330386 | 0.86 | NR3C1 (0.59) | NR3C1MAPK1ALDH1A1CYP2C19HIF1A | |
| SCHEMBL8907648 | 0.80 | NR3C1 (0.56) | NR3C1MAPK1ALDH1A1CYP2C19HIF1A | |
| SCHEMBL94105 | 0.76 | HIF1A (0.63) | NR3C1MAPK1ALDH1A1CYP2C19HIF1A | |
| SCHEMBL7766720 | 0.75 | HIF1A (0.55) | NR3C1MAPK1ALDH1A1CYP2C19HIF1A | |
| SCHEMBL2981243 | 0.75 | HSD17B10 (0.60) | NR3C1MAPK1ALDH1A1CYP2C19HIF1A | |
| SCHEMBL10429009 | 0.75 | NR3C1 (0.76) | NR3C1MAPK1ALDH1A1CYP2C19HIF1A | |
| SCHEMBL10429011 | 0.75 | NR3C1 (0.76) | NR3C1MAPK1ALDH1A1CYP2C19HIF1A | |
| SCHEMBL8903198 | 0.75 | NR3C1 (0.79) | NR3C1MAPK1ALDH1A1CYP2C19HIF1A | |
| SCHEMBL607348 | 0.75 | NR3C1 (0.79) | NR3C1MAPK1ALDH1A1CYP2C19HIF1A | |
| SCHEMBL28318620 | 0.74 | HIF1A (0.60) | NR3C1MAPK1ALDH1A1CYP2C19HIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118339176-A | Engineered myocardial composition | 博德研究所 | 2024-07-12 | — | — | CN | disclosed |
| EP-4381078-A1 | ENGINEERED MUSCLE TARGETING COMPOSITIONS | The Broad Institute, Inc. (US) | 2024-06-12 | — | — | EP | disclosed |
| EP-4373837-A2 | ENGINEERED TARGETING COMPOSITIONS FOR ENDOTHELIAL CELLS OF THE CENTRAL NERVOUS SYSTEM VASCULATURE AND METHODS OF USE THEREOF | The Broad Institute, Inc. (US) | 2024-05-29 | — | — | EP | disclosed |
| CN-118076743-A | Engineered muscle targeting compositions | 博德研究所 | 2024-05-24 | — | — | CN | disclosed |
| US-11920150-B2 | Engineered muscle targeting compositions | THE BROAD INSTITUTE, INC. (US) | 2024-03-05 | — | — | US | disclosed |
| WO-2024035900-A2 | METHODS AND COMPOSITIONS FOR TRANSDUCING HEMATOPOIETIC CELLS | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2024-02-15 | — | — | WO | disclosed |
| WO-2023004367-A9 | ENGINEERED TARGETING COMPOSITIONS FOR ENDOTHELIAL CELLS OF THE CENTRAL NERVOUS SYSTEM VASCULATURE AND METHODS OF USE THEREOF | THE BROAD INSTITUTE, INC. (US) | 2024-01-25 | — | — | WO | disclosed |
| WO-2023225564-A1 | ENGINEERED VIRAL CAPSIDS WITH INCREASED STABILITY AND METHODS OF USE THEREOF | THE BROAD INSTITUTE, INC. (US) | 2023-11-23 | — | — | WO | disclosed |
| WO-2023150632-A2 | TARGETING MOIETIES PROMOTING TRANSDUCTION OF CENTRAL NERVOUS SYSTEM CELLS AND TISSUES AND METHODS OF USE | THE BROAD INSTITUTE, INC. (US) | 2023-08-10 | — | — | WO | disclosed |
| US-20230193316-A1 | ENGINEERED CENTRAL NERVOUS SYSTEM COMPOSITIONS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 2023-06-22 | — | — | US | disclosed |
| EP-4028064-A1 | ENGINEERED ADENO-ASSOCIATED VIRUS CAPSIDS | The Broad Institute, Inc. (US) | 2022-07-20 | — | — | EP | disclosed |
| CN-114729384-A | Engineered adeno-associated virus capsids | 博德研究所 | 2022-07-08 | — | — | CN | disclosed |
| WO-2021222831-A2 | ENGINEERED CENTRAL NERVOUS SYSTEM COMPOSITIONS | THE BROAD INSTITUTE, INC. (US) | 2021-11-04 | — | — | WO | disclosed |
| WO-2021077000-A1 | ENGINEERED MUSCLE TARGETING COMPOSITIONS | THE BROAD INSTITUTE, INC. (US) | 2021-04-22 | — | — | WO | disclosed |
| WO-2021050974-A1 | ENGINEERED ADENO-ASSOCIATED VIRUS CAPSIDS | THE BROAD INSTITUTE, INC. (US) | 2021-03-18 | — | — | WO | disclosed |
| US-10881735-B2 | Phase change nanodroplet conjugates for targeted delivery | ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) | 2021-01-05 | — | — | US | disclosed |
| CN-110573184-A | RNA nanostructures, methods of making and uses thereof | 俄亥俄州立创新基金会 | 2019-12-13 | — | — | CN | disclosed |
| CN-109844109-A | TAT κ-CDKL5 fusion protein, its composition, preparation and purposes | 万校之母-博洛尼亚大学 | 2019-06-04 | — | — | CN | disclosed |
| CN-109196103-A | The 3D RNA cage type nanoparticle of self assembly | 俄亥俄州立创新基金会 | 2019-01-11 | — | — | CN | disclosed |
| US-20180344849-A1 | PHASE CHANGE NANODROPLET CONJUGATES FOR TARGETED DELIVERY | ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA | 2018-12-06 | — | — | US | disclosed |